ASD Device Size to Patient Weight Ratio and Effect on Immediate Complications After Trans Catheter Closure in Pediatric Patients
DOI:
https://doi.org/10.51253/pafmj.v76iSUPPL-4.14171Keywords:
Atrial Septal Defect, Cardiac Catheterization, Heart Septal Defects, Pediatrics, Postoperative ComplicationsAbstract
Objective: To determine ASD device size to patient weight ratio and its effect on immediate complications after transcatheter ASD closure in pediatric patients.
Study Design: Analytical cross sectional study
Place and Duration of Study: Department of Pediatric Cardiology, Armed Forces Institute of Cardiology/ National Institute of Health, Rawalpindi, from August 2025 to December 2025.
Methodology: Thirty-eight pediatric patients (aged 1–12 years, 10–25 kg) with suitable ASD anatomy and symptomatic children were enrolled. Patients with > 25 kg, associated cardiac lesions requiring surgery, active infection, bleeding disorders, or contraindications to catheter intervention were excluded. Defect size was assessed by transthoracic echocardiography, and the ASD device size-to- patient weight ratio of patients was calculated. Patients were monitored for 24 hours postprocedure for immediate complications. Based on observed outcomes, patients were stratified according to device size-to- patient weight ratio for comparative analysis.
Results: The ASD device size-to-patient weight ratio demonstrated a significant association with immediate complications. An optimal cut-off value of 1.53 was identified, dividing patients into a lower-risk group (≤1.53; 21(55.3%)) and a higher-risk group (>1.53; 17 (44.7%)). Overall, immediate complications occurred in 21.1% of patients. Complications were observed in 4.8% of patients in the lower-risk group compared with 41.2% in the higher-risk group, highlighting a substantially higher complication rate associated with increased device-to- .....
Conclusion: An increased ASD device size-to- patient weight ratio is associated with a higher frequency of immediate complications following transcatheter ASD closure. Ratios exceeding 1.53 should be considered cautiously and reserved for cases where clinical benefits ...
Downloads
References
1. Brida M, Chessa M, Celermajer D, Li W, Geva T, Khairy P, et al. Atrial septal defect in adulthood: a new paradigm for congenital heart disease. Eur Heart J. 2022;43(28):2660– 2671.
http://dx.doi.org/10.1093/eurheartj/ehab646
2. Munjal R, H Frishman W. Management of atrial septal defect in the adult population. Cardiol Rev. 2025; Available from:
http://dx.doi.org/10.1097/CRD.0000000000001044
3. Hansen JH, Duong P, Jivanji SGM, Jones M, Kabir S, Butera G, et al. Transcatheter correction of superior sinus venosus atrial septal defects as an alternative to surgical treatment. J Am Coll Cardiol. 2020;75(11):1266–1278. http://dx.doi.org/10.1016/j.jacc.2019.12.070
4. Kalyanasundaram M. Safety and efficacy of larger ASD devices in small children of less than 2 years. Indian Heart J.2021;73(5):637–639.
http://dx.doi.org/10.1016/j.ihj.2021.07.006
5. Hadders-Algra M. Emerging signs of autism spectrum disorder in infancy: Putative neural substrate. Dev Med Child Neurol. 2022;64:1344–1350.
https://doi.org/10.1111/dmcn.15333
6. Houeijeh A, Hascoët S, Bouvaist H, Hadeed K, Petit J, Godart F, et al. Transcatheter closure of large atrial septal defects (ASDs) in symptomatic children with device/weight ratio ≥1.5. Int J Cardiol. 2018;267:84–87.
http://dx.doi.org/10.1016/j.ijcard.2018.05.069
7. Joseph SP, Mirza SUR, Krupa J, Varghese SI, Kartha GB, George OK, et al. Original article--clinical and procedural characteristics of successful transcatheter device closure of ostium secundum atrial septal defect in symptomatic children weighing <15 kg: A retrospective study spanning one decade from south India. J Saudi Heart Assoc. 2024;36(1):14–22.
http://dx.doi.org/10.37616/2212-5043.1365
8. Kashyap T, Sanusi M, Momin ES, Khan AA, Mannan V, Pervaiz MA, et al.
9. Transcatheter occluder devices for the closure of atrial septal defect in children: How safe and effective are they? A systematic review. Cureus. 2022;14(5):e25402.
http://dx.doi.org/10.7759/cureus.25402
10. Noori N, Teimouri A. Evaluation of clinical course in children and adolescents with atrial septal defects. International Journal of Pediatrics [Internet]. 2020 [cited 2026 Jan 2];8(4):11103–11114. Available from: https://jpp.mums.ac.ir/article_13951.html
11. Pillai AA, Satheesh S, Pakkirisamy G, Selvaraj R, Jayaraman B. Techniques and outcomes of transcatheter closure of complex atrial septal defects - single center experience. Indian Heart J. 2014;66(1):38–44. http://dx.doi.org/10.1016/j.ihj.2013.12.016
12. Tanghöj G, Odermarsky M, Naumburg E, Liuba P. Correction to: Early complications after percutaneous closure of atrial septal defect in infants with procedural weight less than 15 kg. Pediatr Cardiol. 2021;42(2):468. http://dx.doi.org/10.1007/s00246-02102550-z
13. Kitano M, Fujimoto K, Kato A, Kurosaki K-I, Shiraishi I. Efficacy and safety of the atrial septal defect closure for patients with absent or malaligned aortic rim using a figulla flex II device flared and straddling behind the aorta. Congenit Heart Dis. 2021;16(3):269–283. http://dx.doi.org/10.32604/chd.2021.015308
14. Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review
15. of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv. 2004;63(4):496–502. http://dx.doi.org/10.1002/ccd.20211
16. Kanwal A, Shiekh AM, Azim K, Khattak KK. Procedural technicalities and outcome of transcatheter closure of atrial septal defect using occlutech device in tertiary care centre. Pak Armed Force Med J. 2021;71(6):2170–2174.
http://dx.doi.org/10.51253/pafmj.v71i6.3342
17. Furugen M, Watanabe N, Nishino S, Kimura T, Ashikaga K, Kuriyama N, et al. Unique mechanism of mitral valve prolapse in atrial septal defect: Three-dimensional insights into mitral complex geometry using real-time transesophageal echocardiography. Echocardiography. 2020;37(3):445–452.:
http://dx.doi.org/10.1111/echo.14623
18. Deaconu S, Deaconu A, Marascu G, Stanculescu MO, Cozma D, Cinteza E, et al. Arrhythmic risk and treatment after transcatheter atrial septal defect closure. Diagnostics (Basel). 2023;14(1):33. http://dx.doi.org/10.3390/diagnostics14010033
19. Dalvi B, Pinto R, Gupta A. Device closure of large atrial septal defects requiring devices≥ 20 mm in small children weighing< 20 kg. Catheterization and Cardiovascular Interventions. 2008;71:679–686. https://doi.org/10.1002/ccd.21450
20. Moore J, Hegde S, El-Said H, Beekman R 3rd, Benson L, Bergersen L, et al. Transcatheter device closure of atrial septal defects: a safety review. JACC Cardiovasc Interv. 2013;6(5):433–442.
Downloads
Published
License
Copyright (c) 2026 Madeeha Ikram, Amjad Mehmood, Maimoona Saeed, Aziz Ullah, Hafiz Muhammad Murtaza

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.





